Inventor
HANS-PETER SCHWARZ
Inventor
AT
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
B01DSeparation16%
C07KPeptides16%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry6%
C12YEnzymes6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,545,703Method to produce an immunoglobulin preparation with improved yield202612,365,723Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS202512,178,861Stabilized liquid and lyophilized ADAMTS13 formulations202411,891,431Removal of serine proteases by treatment with finely divided silicon dioxide202411,564,979Stabilized liquid and lyophilized ADAMTS13 formulations202311,242,380Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use202211,191,837Recombinant VWF formulations202111,136,350Method to produce an immunoglobulin preparation with improved yield2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to TAKEDA PHARMACEUTICALS CO (8)· patent assignee history
2021–2026Based in AT· patent location history
2024Patents assigned to TAKEDA PHARM LTD CEUTICAL COMPANY LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 8 | 2021–2026 |
| TAKEDA PHARM LTD CEUTICAL COMPANY LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| AT | 8 | 2021–2026 |